Early treatment challenges sometimes cause patients to stop prematurely because they mistake slow initial progress for treatment failure
The medication mimics the natural GLP-1 hormone, which is released by the intestines after eating
Additionally, our study confirmed that High GSH intake is an independent risk factor for poor prognosis, offering critical cautionary note for clinical interventions in postoperative breast cancer treatment strategies
DPP4 is a serine exopeptidase that catalyzes the release of an N-terminal dipeptide provided that the next to last residue is proline, hydroxyproline, dehydroproline or alanine
GLP-1 medications and bariatric surgery are not always mutually exclusive
Qin W, Yang J, Ni Y, Deng C, Ruan Q, Ruan J, et al